ClinicalTrials.Veeva

Menu

Severity Factors and Needed Observation Time at ED of Patients Wih Head Injury (HESCTCE)

H

Hospital El Escorial

Status

Unknown

Conditions

Delayed Complications
Length of Stay
Head Injury Other

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT03970421
URGHESCHEADINJURY

Details and patient eligibility

About

We know precisely which patients and when they should have an imaging test to evaluate a Head Injury (HI). But in those patients on anticoagulant and / or antiaggregant treatment we do not know the exact incidence of early and late hemorrhagic lesions, and there is no specific recommendation on how long they should remain under observation in the emergency department if no initial lesions are evident. Our goal is to try to answer these two questions.

Full description

MATERIAL: Prospective study of patients treated of HI in the Emergency Department (ED) and to whom an image test is performed (cranial CT scan). Collection of demographic, clinical, analytical, image tests, and observation time in the emergency department (from admission to medical discharge)

METHODS: Separation of subjects included in the study in 4 cohorts: patients without anticoagulant and / or antiaggregant treatment; patients with antiplatelet therapy (ASA and / or clopidogrel); patients with anticoagulant treatment with acenocoumarol and INR <2; and patients on anticoagulant therapy with acenocoumarol and INR> = 2 or patients on treatment with direct thrombin inhibitors (dabigatran), or inhibitors of factor Xa (rivaroxaban, apixaban, edoxaban) or patients on treatment with low molecular weight heparins (LMWH) ) Follow-up through analysis of clinical history and telephone interview at 2, 7, 15, 30, 60 and 90 days.

Statistical analysis of the results.

Enrollment

300 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HI attended at ED
  • Head CT performed as recommended by clinical guides
  • Contact data available (phone number)

Exclusion criteria

  • Patients not able for follow up (foreigners or tourists or whatsoever whom are not going to stay on the country for at least 3 months)

Trial design

300 participants in 4 patient groups

patients without anticoagulant and / or antiplatelet treatment
Description:
Patients older than 16yo with no anticoagulant or antiplatelet treatment attended at ED because of Head Injury and with a Head CT performed.
Treatment:
Other: Observation
patients on antiplatelet therapy (ASA and / or clopidogrel
Description:
Patients older than 16yo on antiplatelet treatment attended at ED because of Head Injury and with a Head CT performed.
Treatment:
Other: Observation
patients on treatment with acenocoumarol and INR <2
Description:
Patients older than 16yo on acenocumarol and with INR \<2 attended at ED because of Head Injury and with a Head CT performed.
Treatment:
Other: Observation
Others
Description:
patients on anticoagulant therapy with acenocoumarol and INR\> = 2 or patients on treatment with direct thrombin inhibitors (dabigatran), or inhibitors of factor Xa (rivaroxaban, apixaban, edoxaban) or patients on treatment with low molecular weight heparins (LMWH) attended at ED because of Head Injury and with a Head CT performed.
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Central trial contact

Enrique Torres, PhD; Blanca Villacañas, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems